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Approximately 20% of lower extremity vein
grafts (LEVGs) require revision to maintain graft
patency.1-10 As shown by us and others, excellent
assisted primary patency can be maintained with an
aggressive policy of postoperative duplex surveil-
lance and graft revision.1,2,11-13 Occasionally, multi-
ple LEVG revisions may be necessary. The charac-
teristics of recurrent LEVG lesions and the patency
achieved after multiple revisions have not been
reported. This study was performed to determine
(1) the patency of multiply revised LEVGs and (2)
the timing, location, and duplex features of the
recurrent lesions.
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Objectives: Multiple (> 1) revisions of lower extremity vein grafts may be required to
maintain patency. Characteristics of recurrent lower extremity vein graft lesions and the
patency achieved after multiple revisions have not been emphasized in reports on infrain-
guinal vein graft stenosis. This study was performed to determine (1) the patency of
multiply revised lower extremity vein grafts and (2) the timing, location, and angio-
graphic and duplex features of the recurrent lesions.
Methods: Lower extremity vein grafts that were followed in a duplex surveillance proto-
col and required revisions from January 1990 through December 1998 were identified.
All revisions were preceded by angiography. In multiply revised lower extremity vein
grafts, the immediate preoperative angiogram and duplex examination findings, as well
as the angiogram made before the previous revision and the duplex study done after the
previous revision, were reviewed to characterize recurrent lesions at the time of previous
and current graft revision. The patencies of grafts undergoing single and multiple revi-
sions were compared.
Results: A total of 233 lower extremity vein graft revisions were performed; of these, 50
(21%) were repeat revisions. Of grafts requiring more than one revision, 98% were nor-
mal on duplex examination after the initial revision. Five-year assisted primary patency
of multiply revised grafts (91%) was not different from that of grafts with a single revi-
sion (89%; P not significant). Of 60 lesions repaired in the 50 repeat revisions, 29 (48%)
were at the previously revised site, and 31 (52%) were at new sites. The time between
revisions was less if the same site was revised (11 ± 2 months) than if a different site
required revision (20 ± 4 months; P < .05). Arteriographic evidence of a minor (< 50%
diameter) lesion was present at the time of the initial revision in 23% of cases in which
revision of a second site was subsequently required.
Conclusion: In our experience, 21% of lower extremity vein grafts requiring initial revi-
sion ultimately require additional revisions. Multiply revised lower extremity vein grafts
have excellent long-term patency. Lesions occur with equal frequency at the site of prior
revision and new sites. Lesions prompting revision at new sites occur significantly later
and are infrequently detected on prior imaging studies. (J Vasc Surg 2000;32:23-31.)
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METHODS
From January 1, 1990, to December 31, 1998,
1129 LEVGs were performed by the vascular surgi-
cal services of the Oregon Health Sciences
University and the Portland Veteran’s Affairs
Hospital. All patients were prospectively followed up
in a graft surveillance protocol that included history
and physical examination, ankle-brachial index
determination, and duplex examination of the entire
graft, including inflow and outflow vessels. Patients
were evaluated during their initial hospitalization,
every 3 months for the first year, and every 6 months
thereafter. Duplex examinations were performed by
registered vascular technologists using an Acuson
128 duplex scanner (Acuson, Mountain View, Calif)
with either a 5.0- or a 7.5-MHz probe. Criteria for
identifying a graft at risk included a focal peak sys-
tolic velocity (PSV) greater than 200 cm/s, a systolic
velocity ratio (SVR) between an area of suspected
stenosis and the adjacent normal graft of no less than
3.0, the presence of a midgraft velocity less than 45
cm/s, an interval drop in ankle-brachial index
greater than 0.2 between examinations, and/or a
change in clinical status. Arteriography was per-
formed before graft revision. 
All lesions with more than 50% arteriographic
stenosis were repaired. The interval from the finding
of a duplex scan abnormality to arteriography and
revision was less than 30 days in more than 95% of
cases. The type of revision procedure performed
depended on the location and severity of the lesion.
Interposition vein grafts involved placement of a
new vein segment within a graft and not involving
the proximal or distal anastomoses. Proximal revi-
sions and distal extensions involved the creation of
new anastomoses to the native artery with a new
vein segment. Vein patch angioplasty involved place-
ment of a vein patch over a stenosis rather than
placement of a new segment of vein. Infrequently
performed revision procedures included resection of
the stenotic lesion with primary reanastomosis of the
graft and release of externally compressing fascial
bands. Inflow procedures (eg, iliac angioplasty,
stenting, femoral artery interposition grafts, and
extra-anatomic bypass grafts) were occasionally nec-
essary as part of the graft revision. From this data-
base, patients who required multiple (> 1) revisions
to maintain graft patency were identified. We
reviewed the preoperative duplex examination find-
ings, arteriograms, and operative reports to deter-
mine whether secondary revisions were necessary for
new lesions not present at the time of the initial revi-
sion and whether subsequent revisions were at the
site of initial revision.
For new lesions not present at the time of initial
revision, the initial arteriogram was reviewed to
determine if minor (< 50% diameter) lesions were
present at the time of initial revision. The interval
between revisions was also examined, as were the
assisted primary patency, limb salvage, and survival
of patients with multiply revised grafts.
All data were entered into a computer registry
(Paradox for Windows, version 5.0, Borland
International, Scotts Valley, Calif). Statistical analysis
was performed with the χ2 test for frequencies and
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Table I. Demographics of patients undergoing single and multiple LEVG revisions
Multiple revisions Single revision
Demographic (N = 37) (N = 146)
Age at original operation (y ± SD)* 62 ± 10 67 ± 12
Age at revision (y)* 64 ± 10 68 ± 10
Sex
Male (%) 65 71
Female (%) 35 29
Hypertension (%) 68 82
Coronary artery disease (%) 54 51
Smoking history (%) 92 90
Diabetes mellitus 41 40
Cerebrovascular disease (%) 16 30
Prior vascular bypass procedures (%) 46 49
Aortofemoral bypass graft (%) 19 18
Ipsilateral leg bypass graft (%) 22 22
Contralateral leg bypass graft (%) 11 15
End-stage renal disease (%) 5 10
Warfarin therapy (%) 30 31
Hypercoagulable state (%) 8 3
*P < .05.
proportions and the t distribution for comparison of
means. The Kaplan-Meier method with log-rank
analysis or the Wilcoxon test was used to estimate
assisted primary patency, limb salvage, and survival
(JMP, version 3.1.5., SAS Institute, Cary, NC).
RESULTS
Patient demographics. Demographic informa-
tion about patients undergoing single and multiple
bypass graft revision is presented in Table I. Patients
undergoing multiple graft revisions were significant-
ly younger at the time of initial operation and revi-
sion than those undergoing only single revisions (P
< .05; t test). There were otherwise no significant
demographic differences between the two groups.
Characteristics of original operation.
Characteristics of the original operation in patients
undergoing single and multiple graft revisions are
listed in Table II. There was a trend toward fewer
multiple graft revisions when the common femoral
artery was used for inflow (P = .08; χ2 test), but this
did not reach statistical significance.
Characteristics of revision procedures. During
the study period, 233 LEVG revisions were per-
formed in 183 patients. Each of 146 patients under-
went a single revision procedure. Each of 37 patients
underwent multiple (> 1) revisions: 27 patients
required 2 revision procedures, 7 patients required 3
revision procedures, and 3 patients required 4 revi-
sion procedures. Characteristics of the revision pro-
cedures performed in patients requiring both single
and multiple revisions are listed in Table III.
Sites of recurrent lesions. Fifty of the 233 revi-
sions (21.4%) were repeat revisions. Sixty lesions
were repaired. In 21 revisions, the previously revised
site was repaired. In 19 revisions, a new site was
repaired. In eight revisions, both a previously revised
site and a new site were repaired, and in two revi-
sions, two new sites were repaired. 
Of 60 lesions repaired in the repeat revisions, 29
were at the previously revised site (48%). This
included 20 lesions within the body of the graft and
9 involving an anastomosis. Thirty-one lesions
(52%) were at new sites that had not previously
undergone revision. This included 15 new graft
lesions (5 proximal graft, 4 mid graft, and 6 distal
graft), 3 anastomotic lesions, 7 new lesions in the
native arterial inflow to the graft, and 6 new lesions
in the native arterial outflow distal to the graft.
Of the 37 patients in this series, the second revi-
sion was performed only at the site of the initial revi-
sion in 14 (38%), at a different site in 16 (43%), and
at both the initial site and a new, previously unre-
vised site in 7 (16%). Of the 10 patients who
required a third revision, the revised lesions were at
a previously revised site in 6 (60%), at a previously
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Table II. Characteristics of original operation in patients undergoing single and multiple LEVG revisions
Multiple revisions Single revision
(N = 37) (N = 146)
Operation category
Femoral-popliteal (above knee) (%) 11 10
Femoral-popliteal (below knee) (%) 41 41
Femoral-tibial (%) 46 45
Posterior tibial (%) 11 14
Anterior tibial (%) 19 18
Peroneal (%) 16 13
Femoral-pedal 3 3
Inflow
Common femoral artery* (%) 30 47
Superficial femoral artery (%) 35 24
Profunda femoral artery (%) 35 25
Operative indication
Claudication (%) 30 27
Limb salvage (%) 68 73
Rest pain (%) 41 36
Ulcer/gangrene (%) 27 37
Popliteal aneurysm (%) 2 0
Conduit
Reversed saphenous vein graft (%) 70 79
Alternate vein graft (%) 30 21
Single arm vein (%) 5 6
Composite arm/leg (%) 25 15
*P = .08 (χ2).
unrevised site in 3 (30%), and at both a previously
revised and an unrevised site in 1 (10%). Only three
patients required four revisions. A previously revised
site was revised in one patient (33%), and a previ-
ously unrevised site was revised in two patients
(67%).
Patency, limb salvage, survival. Five-year
assisted primary patency of multiply revised grafts
was 91% and did not differ significantly from that of
grafts undergoing a single revision (89%; P not sig-
nificant; Table IV). Likewise, 5-year limb salvage did
not differ between grafts undergoing multiple revi-
sions and grafts undergoing single revisions (89% vs
94%; P not significant; Table V). There was a trend
toward longer 5-year survival in patients who under-
went multiple revisions (89%) than in patients who
underwent only a single revision (78%; P = .08;
Wilcoxon test; Table VI).
Interval between revisions. In patients with
multiply revised grafts, the interval between the ini-
tial operation and the first revision was 15.1 ± 3.5
months (median, 6.6 months). In patients who
underwent only a single revision, the interval
between the original operation and the revision was
22.9 ± 2.6 months (median, 10.0 months). The
interval between initial operation and first revision
did not significantly differ between patients under-
going single revisions and patients undergoing mul-
tiple revisions (P not significant; t test).
The interval between prior and subsequent revi-
sions in patients with multiply revised grafts differed
significantly between patients in whom recurrent
lesions were in the same location as in the previous
revision and patients in whom a different location
required revision. If the same location in the graft
was revised, the interval from the prior revision was
11.3 ± 1.6 months. If a different site required revi-
sion, the interval from the prior revision was 20.4 ±
3.7 months (P < .05; t test).
Prior angiographic evidence of recurrent
lesions. In cases in which a new lesion that led to
repeat vein graft revision was identified, the patient’s
prior arteriogram was reviewed to determine
whether a minor (< 50%) lesion was present. Of the
29 revisions that involved new sites, arteriograms
were reviewed in 26. In three cases, complete arteri-
ograms were not available for review. Of the 26 cases
reviewed, evidence of minor (< 50%) lesions were
present in only six (23%) at the time of prior 
revision.
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Table III. Characteristics of revision procedures in patients undergoing single and multiple LEVG revisions
Multiple revisions (%) Single revision (%)
(N = 37) (N = 146)
Initial revision procedures
Inflow procedure (%) 8 8
Proximal revision (%) 32 33
Interposition (%) 32 28
Vein patch angioplasty (%) 22 23
Distal extension (%) 22 25
Initial revision conduit
Ipsilateral greater saphenous vein (%) 30 22
Contralateral greater saphenous vein (%) 8 12
Basilic vein (%) 30 37
Cephalic vein (%) 16 14
Prosthetic (%) 5 3
Other (%) 11 14
Secondary revision procedures
Inflow procedure (%) 6 —
Proximal revision (%) 34 —
Interposition (%) 26 —
Vein patch angioplasty (%) 8 —
Distal extension (%) 30 —
Other (%) 6 —
Secondary revision conduit
Ipsilateral greater saphenous vein (%) 10 —
Contralateral greater saphenous vein (%) 18 —
Basilic vein (%) 32 —
Cephalic vein (%) 14 —
Prosthetic (%) 14 —
Other (%) 12 —
DISCUSSION
Revision of lower extremity vein grafts is fre-
quently necessary to maintain graft patency. The
need for frequent duplex examination of LEVG has
been demonstrated in numerous studies.1-8,14 With
continued surveillance after the initial revision, some
grafts will develop additional lesions and require
multiple revisions. In this study, we have presented
our experience with 37 patients who have under-
gone 50 secondary graft revisions.
Revised grafts enjoy excellent assisted primary
patency regardless of the number of revisions. Five-
year assisted primary patency was 91% in the multi-
ply revised group versus 89% in grafts undergoing
only a single revision. Others have also reported
excellent assisted primary patency rates in revised
grafts.11-13 Avino et al15 reported comparable out-
comes in repair of primary and recurrent stenoses.
The excellent patency achieved with multiple graft
revisions underscores the prudence of the philoso-
phy of continued duplex surveillance of LEVGs with
repair of stenotic, graft-threatening lesions.
Limb salvage was also comparable between
patients who had single graft revisions and patients
who had multiple graft revisions. Interestingly, there
was a trend toward increased 5-year survival in
patients who underwent multiple revisions. This is
most likely related to the requirement for survival to
undergo multiple revisions; this group of patients
represents one that has preselected itself to survive
multiple operative interventions over the course of
many years. Although the demographic profiles were
similar, patients undergoing multiple graft revisions
were significantly younger at the time of both initial
operation and graft revision.
The type of initial operation and initial operative
indication did not predict the need for multiple graft
revisions. Alternate vein bypass grafts were used in
30% of patients who subsequently required multiple
revisions versus only 21% of those who underwent
only a single revision; however, this was not a statis-
tically significant difference. Likewise, there was a
nonstatistically significant trend toward patients with
common femoral artery inflow at the time of the ini-
tial bypass graft requiring fewer multiple revisions
than those with superficial femoral or profunda
femoral artery inflow. Although the common
femoral artery is the authors’ preferred inflow source
in ideal operative candidates, the use of the superfi-
cial or profunda femoral artery inflow is frequently
required in patients with inadequate conduit, multi-
ple previous groin operations, or severe proximal
arterial disease requiring adjunctive inflow proce-
dures.
Twenty-nine (48%) secondary lesions occurred
at the site of prior revision. These recurring lesions
occurred within the body of the graft in each of 20
cases and involved an anastomosis in each of nine
cases. Thirty-one (52%) lesions developed at new
sites not previously revised; 13 of these lesions
occurred within the native arterial inflow to or out-
flow from the graft. Fifteen of these lesions were
new lesions in the graft, and each of three occurred
at an anastomosis. These lesions developed de novo
in portions of the graft that had been considered
normal at the time of the initial revision. Review of
the arteriograms from the initial revision procedure
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Table IV. Five-year assisted primary patency in grafts undergoing single and multiple revisions
Interval (mo) At risk Occluded Withdrawn Interval patency Cumulative patency SE
A. Single revision
0-1 146 0 0 1.000 1.000 0.0000
2-6 146 2 6 0.986 0.986 0.0099
7-12 138 5 18 0.963 0.948 0.0191
13-24 115 2 29 0.982 0.930 0.0227
25-36 84 1 17 0.988 0.917 0.0256
37-48 66 2 10 0.970 0.886 0.0329
49-60 54 0 15 1.000 0.886 0.0329
B. Multiple revisions
0-2 37 0 0 1.000 1.000 0.0000
2-6 37 0 0 1.000 1.000 0.0000
7-12 37 1 2 0.972 0.972 0.0274
13-24 34 2 2 0.941 0.913 0.0479
25-36 30 0 7 1.000 0.913 0.0479
37-48 23 0 7 1.000 0.913 0.0479
49-60 16 0 3 1.000 0.913 0.0479
P was not significant between singly and multiply revised grafts.
revealed that these new lesions were rarely present at
the time of the initial revision. Arteriographic evi-
dence of minor (< 50%) lesions was present at the
time of initial revision in only 23% of cases.
The cause of recurrent lesions is not certain;
however, the timing of secondary revisions suggests
a possible etiology. When the same site required sec-
ondary revision, the mean time between revision
procedures was less than 1 year. If a new site
required secondary revision, the mean time between
the initial and subsequent revision was more than 20
months (P < .05). This corresponds with a fre-
quently accepted theory regarding restenosis. If
restenosis occurs within the first year, intimal hyper-
plastic mechanisms are generally considered
causative, whereas restenosis that occurs after the
first year is believed to be due to recurrent athero-
sclerotic disease.16,17
The fact that new lesions can occur in segments
of the graft that previously appeared normal under-
scores the value of regular, lifelong duplex graft sur-
veillance. Although some groups have suggested
that only patients with early graft duplex abnormali-
ties require diligent follow-up,18,19 these data clear-
ly indicate both that revised grafts are susceptible to
restenosis and that new sites can develop lesions
long after both the initial operation and the initial
revision procedure. The mean interval between revi-
sions (11 months for restenosis, 20 months for
stenosis at a different site) underscores the need for
continued surveillance.
In summary, excellent assisted primary graft
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Table V. Five-year limb salvage in patients undergoing single and multiple LEVG revisions
Interval (mo) At risk Amputated Withdrawn Interval salvage Cumulative salvage SE
A. Single revision
0-1 146 0 0 1.000 1.000 0.0000
2-6 146 1 6 0.993 0.993 0.0068
7-12 139 1 21 0.993 0.986 0.0140
13-24 117 4 28 0.966 0.950 0.0202
25-36 85 0 18 1.000 0.950 0.0202
37-48 67 1 11 0.985 0.936 0.0244
49-60 55 0 15 1.000 0.936 0.0244
B. Multiple revisions
0-1 37 0 0 1.000 1.000 0.0000
2-6 37 0 0 1.000 1.000 0.0000
7-12 37 0 3 1.000 1.000 0.0000
13-24 34 2 4 0.941 0.940 0.0410
25-36 28 0 7 1.000 0.940 0.0410
37-48 21 1 5 0.952 0.891 0.0619
49-60 15 0 3 1.000 0.891 0.0619
P was not significant between singly and multiply revised grafts.
Table VI. Five-year survival in patients undergoing single and multiple LEVG revisions 
Interval (mo) At risk Deceased Withdrawn Interval survival Cumulative survival SE
A. Single revision
0-1 146 0 0 1.000 1.000 0.0000
2-6 146 1 5 0.993 0.993 0.0070
7-12 140 5 17 0.964 0.956 0.0174
13-24 118 2 28 0.983 0.938 0.0211
25-36 88 6 14 1.932 0.871 0.0331
37-48 68 2 11 0.971 0.845 0.0367
49-60 55 4 11 1.927 0.779 0.0466
B. Multiple revisions
0-1 37 0 0 1.000 1.000 0.0000
2-6 37 0 0 1.000 1.000 0.0000
7-12 37 0 3 1.000 1.000 0.0000
13-24 34 0 5 1.000 1.000 0.0000
25-36 29 0 7 1.000 1.000 0.0000
37-48 22 2 5 0.909 0.889 0.0741
49-60 15 0 3 1.000 0.889 0.0741
P = .08 by Wilcoxon test between patients undergoing single and multiple revisions.
patency can be achieved in LEVGs even if multiple
revisions are required. Secondary revisions are
required with almost equal frequency at the site of
prior revision and at new, previously unrevised sites.
The difference in timing of revision between these
two groups suggests a possible difference in etiolo-
gy. New lesions are infrequently suggested by the
arteriograms from the initial revision. Regular, life-
long duplex surveillance appears essential to identify
these grafts at risk.
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DISCUSSION
Dr George Andros (Los Angeles, Calif). The program
committee should be congratulated doubly, first for
including this paper in the program and second for start-
ing the proceedings with such high-quality work. In the
past the senior author has made us aware of Sackett’s five
levels of evidence to evaluate clinical investigations.
Prospective, blinded, randomized, rank as 1, and retro-
spective clinical series, the so-called hypothesis seeking
investigations, received a lowly 5. This study would rank
about a Sackett 3. The manuscript, which I commend to
you all, is a cornucopia of interesting clinical data. In addi-
tion, it sets the standard for outstanding results in the
surgery/surveillance tandem for the management of these
very difficult patients. Simply put, an assisted primary
patency rate of more than 90% is nothing to sneeze at.
Let me recapitulate briefly some of Dr Landry’s many
interesting observations. Over 9 years, 1129 lower
extremity vein grafts were performed presumably for
chronic ischemia. The patients underwent prospective clin-
ical and ultrasonic graft surveillance. Several excellent cri-
teria were selected to identify the so-called graft at risk. All
such grafts were further studied by arteriography within
the month of their identification.
A few questions come to mind. In addition to the 1129
lower extremity vein grafts, how many prosthetic vein
grafts were implanted and were they included in the sur-
veillance program?
Since your manuscript did not include a mean follow-
up duration, I was unable to calculate the total number of
surveillance studies required, on average, to identify a graft
that goes on to revision and hence further on to re-revision.
Is a guess of 40 studies per revision too high or too low?
All of the ultrasonically detected lesions were further
evaluated by angiogram, and nearly all of the angiogram
lesions were repaired. I believe that your excellent, assisted
primary patency results support your surveillance criteria and
the use of both kinds of graft interrogation. But if you invert
the process, how many grafts slip through the surveillance
net and thrombose despite a normal duplex surveillance?
This question takes on special importance because of your
finding that about 50% of the re-revisions were for new
lesions in segments previously known to be free of stenosis.
Your paper is a testimony to the art of infrainguinal
revascularization. Your 1°, 2°, and 3° revisions included
inflow and outflow jump grafts, patch angioplasty, inter-
position grafts, and graft resection with reanastomosis.
Moreover, your choice of revision conduits was diverse
encompassing arm and leg veins, and remnants and there
were even some balloon angioplasties! I congratulate you
for your innovation and your doggedness.
I would like your opinion on revision nomenclature.
Inflow PTA that never touches the primary graft and
direct graft manipulation both confer so-called assisted
primary patency to a conduit. Is there a better nomencla-
ture to stratify such dissimilar interventions? I do not
know of a better descriptive nosology, but I think that
there should be one.
Finally, some questions on lesions more extensive than
simple stenosis. We have seen long secondary graft
stenoses, many centimeters in length, that require replace-
ment of a substantial portion of the graft. Have you seen
any such lesions? Have you detected any lesions that were
so severe as to be unrevisable? Among stenotic secondary
graft lesions we have seen saphenous and arm vein
aneurysmosis, both focal and diffuse, virtually always in
patients operated on for popliteal aneurysm. Peter Bell has
recently confirmed this finding. Has your surveillance pro-
gram identified any vein graft aneurysms? I was surprised
at your very good 5-year patient survival. Could you
explain that?
The rational management of infrainguinal arterioscle-
rotic occlusive disease is based on three principles: knowl-
edge of the natural history of the untreated disease,
knowledge of the natural history of the treated disease,
and knowledge of the natural history of treatment, or in
this case, the bypass graft. This paper is exemplary and
indispensable because it provides practical information on
each of these principles.
In summary, the Oregon group has turned the crank
on its leg bypass/graft surveillance mill, and a very useful
paper has emerged. No one should doubt that the crank
will be turned many times again in the future and appro-
priately so. The beneficiaries will be their patients and our
improved knowledge of how to manage lower extremity
ischemia. But for today, the lesson is that sedulous graft
surveillance and graft revision pays off.
Dr Gregory Landry. Thank you, Dr Andros. I shall try
to answer your questions sequentially.
The first question was regarding the use of prosthetic
bypasses. Our policy is to use all autogenous conduit when
available in performing lower extremity vein bypasses. It is
exceedingly rare that we would use a prosthetic conduit
for an initial bypass, and in this particular series, all of the
patients had autogenous conduit for their bypass. There
were no prosthetic grafts in this series.
For your second question with regard to mean follow-
up, I am sorry that I do not have mean follow-up data at
my disposal right now. However, your estimation of
approximately 40 studies per patient is probably within
ballpark range.
With respect to grafts that slipped through the cracks
and occluded despite having a normal duplex surveillance
study, I think that this is a very rare occurrence in our
practice. Certainly we cannot have 100% compliance with
every patient, and from time to time we do see grafts that
do occlude without any prior evidence of duplex stenosis.
However, my impression is that this is exceedingly rare.
Your fourth question was regarding revision nomen-
clature. For this particular series we only included grafts in
which the actual graft was included in the revision. From
time to time we do have patients who undergo inflow pro-
cedures, both iliac angioplasty or fem-fem bypasses or
other types of inflow procedures in which the graft itself is
not touched, but for this particular series we included only
grafts in which the graft itself was included in the revision.
The fifth question had to do with the occasional graft
that is unreconstructible. Again, we do see this from time
to time, but it is exceedingly rare. If the whole graft
required replacement, those particular patients were not
included in this study.
The sixth question had to do with the occurrence of
vein graft aneurysms. There were no aneurysmal vein grafts
that were revised in this series. Only one patient in this
series had his initial procedure performed for aneurysm,
but in that one patient neither of the subsequent revisions
was due to an aneurysm within the graft itself.
And finally, with regard to survival, I would agree that
the 5-year survival that we report seems somewhat high. My
explanation for this is that patients who undergo graft revi-
sions, particularly if they undergo multiple graft revisions,
have essentially preselected themselves to long-term sur-
vival. In other words, you have to survive in order to under-
go multiple revisions. I hope that answered your questions.
Dr Robert Rutherford (Denver, Colo). Thank you. I
have a couple of questions here, mainly for clarification.
You have reported your assisted primary patency rate, but
by the reporting standards you should also report your
primary patency rates between those two groups.
They could be quite different, even if the assisted prima-
ry patency rates were the same. You might have had to inter-
vene many more times, successfully, in one group, yet still
end up with the same assisted primary patency rates. So I
would like to know what the primary patency rates are
between the multiply revised and the singly revised groups.
The second question I have is about your surveillance
program. Once you have a graft that has been revised, do
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you put it permanently on an every 3-month surveillance
or do you go back to your original protocol of every 3
months just for the first year?
And finally, you have previously reported your experi-
ence with vein grafts other than greater saphenous vein,
like arm veins and lesser saphenous veins and veins spliced
together from various sites. Was there a difference in terms
of the type of veins that you used in regard to those
requiring multiple revisions?
Thank you very much. I enjoyed the paper.
Dr Landry. Thank you, Dr Rutherford. In terms of the
primary patency in this particular series, I am sorry that I
do not have those particular data. We have previously
reported primary patency of lower extremity grafts in the
range of 50% to 60%, and I would assume that the results
from this series are essentially the same.
With regard to the duplex surveillance protocol, after
patients undergo revision, they essentially start over in the
duplex surveillance protocol. They receive a duplex exam-
ination after their revision, and then every 3 months after
the time of that revision. If they make it for that first year
after revision without any further problems, they once
again go to the every 6-month follow-up.
With respect to the use of alternate vein, in patients
who underwent a single graft revision, approximately 80%
had saphenous vein for the initial conduit, and 20% had an
alternate vein. In patients who underwent multiple revi-
sions, the initial conduit was 70% saphenous vein, 30%
alternate vein, but there were no significant differences
between those two groups.
Dr Mark Nehler (Denver, Colo). When you have a
patient with a recurrent lesion at a site you have done a
previous revision, do you handle that any differently tech-
nically?
Dr Landry. There is no specific strategy. The way we
revise grafts is if an interposition graft is placed, to make
sure that the proximal or distal anastomosis for the inter-
position is at normal segments of vein. So we do the best
that we can to find a normal segment of vein to do that
anastomosis, too, and the same holds true with revising
the graft proximally or distally.
Our approach toward the multiple revisions is essen-
tially the same toward the approach toward single revision
in making sure that either a normal autogenous artery or
a normal portion of vein is used for the revision.
I should mention that for the initial revision, approxi-
mately 25% of the revisions were vein patch angioplasties and
a number of those recurred at the same site. So if initially we
performed a vein patch angioplasty for the subsequent re-
revision, we would most likely do a short interposition graft.
Dr Joseph Mills (Phoenix, Ariz). I enjoyed that. I just
have one comment and then one question. My comment
is that I am struck how similar data are from different cen-
ters. I mean, our data, for a long time now, show pretty
much what you have reported today. About 80% of the
grafts have a solitary lesion at the time of their initial
recognition of the lesion. Then when you follow those
grafts, about 20% of the ones that get revised get recurrent
lesions, and I think those figures seem to hold up for mul-
tiple different centers. I think that suggests something
about the biological behavior of vein grafts.
You have pointed out that in your multiply revised
grafts more of those seemed to have inflow other than the
common femoral. That raises two questions. Was there
something that you recognized that was wrong with the
vein at the primary operation so you compromised it to
make your graft shorter? Does it reflect bad vein from the
initial operation for a higher revision rate?
Then how many of those revisions included inflow
procedures? So because of compromising the initial oper-
ation with a shorter graft, did you have to do something
like a proximal inflow reconstruction or do a common
femoral vein graft bypass to replace a segment or were
those not included? Thank you.
Dr Landry. We would preferentially perform a lower
extremity vein graft using common femoral inflow.
Unfortunately, in our patient population that is not always
possible. A number of our patients have had prior bypass
operations on that leg. A number of them have had their
saphenous veins used. So we do have a fairly high fre-
quency of patients who are undergoing repeat operations
with alternate vein conduits.
We also have a number of patients who require distal
tibial bypasses. For that reason we do not always have long
enough vein segments to always come off of the common
femoral artery. The fact that patients who have inflow
from the superficial femoral artery and profunda femoral
artery require multiple revisions, in our opinion, is not
necessarily a bad thing.
As we pointed out, their patency is actually quite
good. The problem is that they do require a little bit more
maintenance over the long term, but in our opinion, using
either the superficial femoral artery or the profunda
femoral artery as inflow is an adequate alternative if the
initial situation is not perfect for using the common
femoral artery as inflow.
In terms of inflow procedures that were performed as
part of the bypass, that occurred approximately 10% of the
time; an iliac angioplasty, a femoral interposition graft, or
extra-anatomic bypass was performed to improve the inflow.
So those were included in the series, but the grafts themselves
were considered separately in terms of the data analysis.
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